Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LLY – Eli Lilly and Company

Eli Lilly and Company
LLY
$884.54
Name : Eli Lilly and Company
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $794,307,133,440.00
EPSttm : 11.68
finviz dynamic chart for LLY
Eli Lilly and Company
$884.54
2.89%
$24.81

Float Short %

0.83

Margin Of Safety %

-21

Put/Call OI Ratio

1.0393929974284

EPS Next Q Diff

0.22

EPS Last/This Y

10.78

EPS This/Next Y

7.21

Price

884.54

Target Price

1024.93

Analyst Recom

1.34

Performance Q

12.62

Relative Volume

0.93

Beta

0.48

Ticker: LLY




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-27LLY821.20.961.39255739
2025-03-28LLY821.560.961.06260856
2025-03-31LLY825.570.980.98244042
2025-04-01LLY804.890.990.94253461
2025-04-02LLY817.661.000.81260791
2025-04-03LLY788.941.000.85266171
2025-04-04LLY738.60.981.07269106
2025-04-07LLY723.621.011.08252173
2025-04-08LLY726.610.991.09259492
2025-04-09LLY753.61.000.78268193
2025-04-10LLY719.140.980.93279608
2025-04-11LLY732.170.981.08286906
2025-04-14LLY754.351.010.77271252
2025-04-15LLY757.081.000.87277999
2025-04-16LLY734.630.991.27282339
2025-04-17LLY839.150.980.87285375
2025-04-18LLY839.960.980.88285375
2025-04-21LLY818.021.041.46259705
2025-04-22LLY827.121.040.68270827
2025-04-23LLY829.561.040.68276386
2025-04-24LLY858.381.050.62283033
2025-04-25LLY884.541.03939299742840.5379758823158288672
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-27LLY821.4182.112054.223.22
2025-03-28LLY822.5182.112239.223.22
2025-03-31LLY825.9182.112316.023.22
2025-04-01LLY805.2382.111596.323.22
2025-04-02LLY818.2281.912611.523.21
2025-04-03LLY789.0981.911336.023.21
2025-04-04LLY738.5981.910637.923.21
2025-04-07LLY723.3181.911718.423.19
2025-04-08LLY726.2481.912299.023.19
2025-04-09LLY752.5681.913103.223.19
2025-04-10LLY720.7482.511138.923.28
2025-04-11LLY732.1382.012595.723.27
2025-04-14LLY754.3582.012949.323.27
2025-04-15LLY757.1881.312306.223.25
2025-04-16LLY734.4272.411475.123.11
2025-04-17LLY839.9672.415372.523.11
2025-04-18LLY839.9672.411904.923.00
2025-04-21LLY817.9866.411266.723.00
2025-04-22LLY827.5462.312188.522.94
2025-04-23LLY829.4251.411960.322.72
2025-04-24LLY860.0041.312803.822.54
2025-04-25LLY884.5441.312609.522.54
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-27LLY-0.89-5.510.75
2025-03-28LLY-0.89-5.510.75
2025-03-31LLY-0.89-5.510.75
2025-04-01LLY-0.89-5.510.75
2025-04-02LLY-0.89-5.510.75
2025-04-03LLY-0.89-5.510.75
2025-04-04LLY-0.89-5.510.75
2025-04-07LLY-0.89-5.510.75
2025-04-08LLY-0.89-5.510.75
2025-04-09LLY-0.89-5.510.75
2025-04-10LLY-0.89-5.510.83
2025-04-11LLY-0.89-5.510.83
2025-04-14LLY-0.89-5.510.83
2025-04-15LLY-0.89-5.510.83
2025-04-16LLY-0.89-5.510.83
2025-04-17LLY-0.89-5.510.83
2025-04-18LLY-0.89-5.510.83
2025-04-21LLY-0.89-5.530.83
2025-04-22LLY-0.89-5.530.83
2025-04-23LLY-0.89-5.530.83
2025-04-24LLY-0.89-5.530.83
2025-04-25LLY-0.89-5.530.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

5.32

Avg. EPS Est. Current Quarter

4.7

Avg. EPS Est. Next Quarter

5.54

Insider Transactions

-0.89

Institutional Transactions

-5.53

Beta

0.48

Average Sales Estimate Current Quarter

12786

Average Sales Estimate Next Quarter

14345

Fair Value

702.65

Quality Score

96

Growth Score

99

Sentiment Score

72

Actual DrawDown %

9

Max Drawdown 5-Year %

-24.7

Target Price

1024.93

P/E

76.99

Forward P/E

29.59

PEG

1.83

P/S

18.62

P/B

59.06

P/Free Cash Flow

223.01

EPS

11.49

Average EPS Est. Cur. Y​

22.54

EPS Next Y. (Est.)

29.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

23.51

Relative Volume

0.93

Return on Equity vs Sector %

53.4

Return on Equity vs Industry %

45.3

EPS 1 7Days Diff

-0.6

EPS 1 30Days Diff

-0.72

EBIT Estimation

12609.5
Eli Lilly and Company
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 47000
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
stock quote shares LLY – Eli Lilly and Company Stock Price stock today
news today LLY – Eli Lilly and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch LLY – Eli Lilly and Company yahoo finance google finance
stock history LLY – Eli Lilly and Company invest stock market
stock prices LLY premarket after hours
ticker LLY fair value insiders trading